ECOR vs OM: stock comparison and AI forecast
Electrocore, Inc. (ECOR) and Outset Medical, Inc. (OM) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ECOR Electrocore, Inc.
- Price
- $8.80 +40.4% · 6M
- Market Cap
- $79M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
OM Outset Medical, Inc.
- Price
- $4.15 -13.0% · 6M
- Market Cap
- $77M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ECOR and OM have similar market capitalizations ($79M and $77M).
- Over the last six months ECOR returned +40.4% and OM -13.0%.
- Both companies share the SEC industry classification Electromedical & Electrotherapeutic Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ECOR | OM |
|---|---|---|
| Market Cap | $79M | $77M |
| P/B Ratio | – | 0.93x |
| EPS | $-1.38 | $-2.45 |
| Book Value/Share | – | $4.43 |
| Revenue/Share | $4.21 | $6.49 |
| FCF/Share | $-1.21 | $-2.28 |
Profitability & Margins
| Metric | ECOR | OM |
|---|---|---|
| ROA | -73.6% | – |
| ROIC | -194.3% | -33.6% |
| Gross Margin | 87.7% | 42.0% |
| Operating Margin | -33.1% | -51.2% |
| Net Margin | -33.5% | – |
| EBT Margin | -34.5% | -57.8% |
| Tax Rate | 3.0% | -1.0% |
Financial Health
| Metric | ECOR | OM |
|---|---|---|
| Current Ratio | 1.34x | 4.86x |
| Quick Ratio | 0.97x | 3.85x |
| D/E Ratio | – | 1.77x |
| Financial Leverage | – | 2.77x |
| Interest Coverage | -420.5x | -3.5x |
| Working Capital | $4M | $172M |
Cash Flow
| Metric | ECOR | OM |
|---|---|---|
| Operating Cash Flow | -$11M | -$42M |
| Free Cash Flow | -$11M | -$43M |
| Capital Spending | -$10K | -$510K |
| FCF/Sales | -28.7% | -35.2% |
| CapEx/Sales | 0.0% | 0.4% |
Operational Efficiency
| Metric | ECOR | OM |
|---|---|---|
| Asset Turnover | 2.20x | 0.53x |
| Receivables Turnover | 23.4x | 4.0x |
| Inventory Turnover | 1.2x | 1.6x |
| Fixed Assets Turnover | 102.3x | 34.4x |
| Days Sales Outstanding | 16 days | 91 days |
| Days Inventory | 309 days | 232 days |
| Payables Period | 268 days | 22 days |
| Cash Conversion Cycle | 56 days | 301 days |
Income Statement
| Metric | ECOR | OM |
|---|---|---|
| Total Revenue | $38M | $122M |
| Operating Income | -$13M | -$62M |
| Net Income | -$13M | – |
| R&D Expense | $3M | $22M |
| SG&A Expense | $43M | $116M |
| Cost of Goods Sold | $5M | $71M |
Dividend & Shareholder Information
| Metric | ECOR | OM |
|---|---|---|
| Shares Outstanding | 9M | 19M |
ECOR vs OM: stock comparison and AI forecast
Which is bigger, ECOR or OM?
ECOR and OM have similar market capitalizations ($79M and $77M).
Which stock performed better over the last six months, ECOR or OM?
Over the last six months ECOR returned +40.4% and OM -13.0%.
Which one does Intratio's AI model rank higher, ECOR or OM?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.